{'fraction_non_alphanumeric': 0.026993865030674847, 'fraction_numerical': 0.0098159509202454, 'mean_word_length': 5.229007633587786, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Glycated hemoglobin measurement in diabetes mellitus.

Nurse practitioners (NP~) , asprimary care providers, determine and evaluate care for a wide selection of chronic conditions in a variety of patient populations. One of the most prevalent chronic disease processes is diabetes mellitus (DM) , which affects approximately 11 million people in the United States (U.S. Preventive Services Task Force, 1989). Determining the success of a patient’s regimen for control of diabetes is uncertain with simple glucose testing. The addition of a glycated hemoglobin (Hgb) assay provides information on the glycemic levels of patients for a period of 2 to 3 months prior to blood sampling. The analysis of hemoglobin AlC content augments other standard laboratory testing for the optimum determination of glycemic control.